Atul Chopra

Technik-/Wissenschafts-/F&E-Leiter bei Aceragen, Inc. (North Carolina)

Vermögen: 968 947 $ am 31.07.2023

Health Technology

Profil

Atul Chopra is associated with Aceragen, Inc. (North Carolina) as a Scientific Advisor.

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
ACERAGEN, INC. 14,31%	19.07.2023	1 205 158 ( 14,31% )	968 947 $	31.07.2023

Unternehmen	Position	Beginn
Aceragen, Inc. (North Carolina) Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022.	Technik-/Wissenschafts-/F&E-Leiter	01.03.2021

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Private Unternehmen	1
Aceragen, Inc. (North Carolina) Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022.	Health Technology

Private Unternehmen

Health Technology